What does JHL Biotech do?
JHL Biotech is a biopharmaceutical company that develops its own portfolio of biosimilar products, co-develops innovative new protein therapeutics, and provides contract development and manufacturing services to select emerging biopharmaceutical firms.
What is JHL’s vision?
JHL Biotech will make world-class biologics available to all patients who need them.
What is JHL’s mission?
JHL Biotech is a vertically-integrated firm focused only on development and manufacturing of biotherapeutics. We have our own labs and manufacturing facilities, giving us control over all aspects of the biologics development and production process. By applying the latest advances in chemistry, manufacturing, and control science, we reduce the cost of producing biotherapeutics, and we make biologics more affordable by using our technology platform to create our own portfolio of biosimilars and to help others develop biotherapeutics in a cost-effective manner.
When is JHL Biotech Incorporated?
JHL Biotech, Inc. was incorporated in the Cayman Islands on December 13, 2012. In 2013, subsidiaries in both Taiwan and China were established.
Where is JHL headquartered?
JHL’s corporate headquarters is located at:Hsinchu biomedical Science park
3F, No.18, Sec. 2 Shengyi Rd., Zhubei City,
Hsinchu County 302, Taiwan (R.O.C.)
When does JHL’s fiscal year-end?
JHL’s fiscal year end is 31st December.
Who is JHL’s auditor?
On which exchange is JHL listed, what is the ticker number, and when did JHL go public?
JHL common shares are traded under the ticker number “6540” on the Taiwan Emerging Market Board. JHL publicly listed shares on the Taiwan Emerging Market Board on 14 Sep 2015.
How do I contact JHL with additional questions or inquiries?
Please submit an inquiry via our contact form.
Where can I view public information on JHL Biotech, Inc.?
The Taiwan Stock Exchange (TSE) Market Observation System (MOPS) provides public information on various financial reports and other corporate information filed with the TSE.